Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc.（TMCI）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · TMCI · 截至 2025年9月30日
股东结构概览
119
机构持有人数
▼ 5 vs Q2
$382.50M
机构持仓总市值
▲ $156.43M vs Q2
64.87M
总流通股
freeFloat 72.90%
57.04M
13F 申报持股数
▲ 18.60M vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
TMCI 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
surgical & medical instruments & apparatus | 18.21M | 28.90% | 28.90% | $122.20B | Nov 12, 2025 | NEW |
ARMISTICE CAPITAL, LLC surgical & medical instruments & apparatus | 6.32M | 10.02% | 10.02% | $42.38B | Nov 17, 2025 | ▲ 56.0K |
BLACKROCK, INC. surgical & medical instruments & apparatus | 3.68M | 5.84% | 5.84% | $24.71B | Nov 12, 2025 | ▼ 84.0K |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC surgical & medical instruments & apparatus | 3.63M | 5.77% | 5.77% | $24.39B | Nov 12, 2025 | ▲ 534.5K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 2.73M | 4.34% | 4.34% | $18.33B | Nov 7, 2025 | ▲ 6.2K |
GAGNON SECURITIES LLC surgical & medical instruments & apparatus | 2.26M | 3.58% | 3.58% | $15.15B | Nov 3, 2025 | ▲ 8.1K |
MILLENNIUM MANAGEMENT LLC surgical & medical instruments & apparatus | 1.71M | 2.71% | 2.71% | $11.48B | Nov 14, 2025 | ▲ 192.9K |
CIBC PRIVATE WEALTH GROUP, LLC surgical & medical instruments & apparatus | 1.69M | 2.68% | 2.68% | $11.32B | Nov 24, 2025 | ▼ 1.0K |
JPMORGAN CHASE & CO surgical & medical instruments & apparatus | 1.61M | 2.56% | 2.56% | $10.83B | Nov 26, 2025 | ▼ 163.7K |
FIRST EAGLE INVESTMENT MANAGEMENT, LLC surgical & medical instruments & apparatus | 1.24M | 1.97% | 1.97% | $8.31B | Nov 12, 2025 | ▲ 330.9K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
25
增持
+1.81M 股4
新建仓
首次建仓14
减持
−1.20M 股0
清仓
完全退出净股数变化（前50家）
+613.4K
+1.81M / −1.20M
净新增持仓人
+15
新建 4 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
TMCI 内幕交易记录
数据来源：SEC Form 4
近期内部人员净买入。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
14
买入笔数
1
卖出笔数
14.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Treace John T. Chief Executive Officer | Jun 1, 2026 | Purchase | 50,000 | $3.56 | $177.9K | 7.32M | Form 4 ↗ |
Treace John T. Chief Executive Officer | May 28, 2026 | Purchase | 61,202 | $3.02 | $184.8K | 7.27M | Form 4 ↗ |
Treace John T. Chief Executive Officer | May 27, 2026 | Purchase | 49,810 | $2.87 | $143.2K | 7.21M | Form 4 ↗ |
Treace John T. Chief Executive Officer | May 26, 2026 | Purchase | 4,508 | $2.79 | $12.6K | 7.16M | Form 4 ↗ |
BAKEWELL JOHN K director | May 19, 2026 | Award | 30,000 | — | — | 204.1K | Form 4 ↗ |
Kiernan Jane E director | May 19, 2026 | Award | 30,000 | — | — | 93.9K | Form 4 ↗ |
Berry Lance A director | May 19, 2026 | Award | 30,000 | — | — | 74.6K | Form 4 ↗ |
Jain Deepti director | May 19, 2026 | Award | 30,000 | — | — | 100.2K | Form 4 ↗ |
HAMILTON LAWRENCE W director | May 19, 2026 | Award | 30,000 | — | — | 74.1K | Form 4 ↗ |
Hanna Betsy director | May 19, 2026 | Award | 30,000 | — | — | 75.2K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Treace Medical Concepts, Inc.（TMCI）主要由机构投资者持有，机构持股比例约为 87.9%。公司内部人员持股约 27.10%，散户及公众持股约占剩余的 0.00%。
Treace Medical Concepts, Inc. 最大机构股东为 ，截至 September 30, 2025 持有约 18.21 million 股，占总流通股的 28.90%。
目前共有 119 家机构持有 TMCI 股票，合计持仓市值约 $382,498,297，数据来源为最新 SEC 13F 申报。
常见问题
TMCI ownershipTreace Medical Concepts, Inc.（TMCI）主要由机构投资者持有，机构持股约 87.9%。最大股东为 ，持股比例 28.90%。内部人员持股约 27.10%。数据来源 SEC Form 13F，截至 September 30, 2025。